Max Wallace's most recent trade in Humacyte Inc was a trade of 80,000 Stock Options (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Humacyte Inc | Max Wallace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 80,000 | 80,000 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Max Wallace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 50,000 | 50,000 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Max Wallace | Director | Purchase of securities on an exchange or from another person at price $ 6.21 per share. | 20 May 2024 | 4,015 | 4,015 | - | 6.2 | 24,933 | Common Stock |
| Humacyte Inc | Max Wallace | Director | Purchase of securities on an exchange or from another person at price $ 6.29 per share. | 20 May 2024 | 3,990 | 3,990 | - | 6.3 | 25,097 | Common Stock |
| Humacyte Inc | Max Wallace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,500 | 8,500 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Max Wallace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 8,500 | 8,500 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Max Wallace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 8,500 | 8,500 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Max Wallace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 49,986 | 49,986 | - | - | Common Stock | |
| Humacyte Inc | Max Wallace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 17,068 | 17,068 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Max Wallace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 13,129 | 13,129 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Max Wallace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 6,564 | 6,564 | - | - | Stock Options (right to buy) |